KALAMAZOO – Metabolic Solutions Development Co., a therapeutics company, is the sixth investment for the Southwest Michigan First Life Sciences Fund.
The company was founded in Kalamazoo in 2006 by two retired Pfizer scientists, Rolf Kletzien, PhD, and Jerry Colca, PhD. Their scientific strategy is build on understanding insulin-sensitizing thiazolidinediones to create a new generation of more effective and safe drug therapies for the 150 million people worldwide afflicted with diabetes. Other products in development are currently being evaluated for their ability to impact other diseases caused by metabolic inflammation.
?The support of the Southwest Michigan First Life Science Fund will help us bring a fresh approach to pharmaceutical research in Kalamazoo and take us closer to our long-term goal of treating and preventing diabetes and its life-shortening complications,? said Colca, who serves as president.
Ron Kitchens, Fund General Partner and CEO of the Southwest Michigan First economic development organization said the strength of Metabolic Solution discovery pipeline is what attracted the fund?s attention.
The Southwest Michigan First Life Science Fund is a $50 million limited partnership venture fund interested in early stage life sciences opportunities in southwest Michigan that have demonstrably viable technologies and are committed to establishing a presence in the Region.
For more information, click on MSDRX.Com
a>>
